Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours

Jordi Rodón, Guillem Argilés, Roisín M. Connolly, Ulka N. Vaishampayan, Maja J.A. de Jonge, Elena Garralda, Marios Giannakis, David C. Smith, Jason R. Dobson, Margaret E. McLaughlin,

British Journal of Cancer · 2021 · 160 citations · 27 references

DOIFull text

Open access

Concepts

References

27